Publications by authors named "Yuji Heike"

Claim this Profile
P
Photoactivatable Materials for Versatile Single-Cell Patterning Based on the Photocaging of Cell-Anchoring Moieties through Lipid Self-Assembly.
Shinya Yamahira, Ryuji Misawa, Takahiro Kosaka, Mondong Tan, Shin Izuta, Yuji Heike

J Am Chem Soc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural adjuvants ( and ) induce activated natural killer cells with NKG2D expression and cytotoxic properties in colorectal cancer.
Ali Khodadadi, Abdolhassan Talaiezadeh, Yuji Heike, Hamid Galehdari, Mojtaba Oraki Kohshour

Gastroenterol Hepatol Bed Bench· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience.
Somayeh Rezaeifard, Yuji Heike, Jun-Ichi Masuyama, Alireaz Rezvani, Reza Vojdani

Iran J Allergy Asthma Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Nobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, Rie Yamazaki-Itoh, Chie Naito, Yuji Heike

Cancer Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facile Fabrication of Thin-Bottom Round-Well Plates Using the Deformation of PDMS Molds and Their Application for Single-Cell PCR.
Shinya Yamahira, Yuji Heike

Micromachines (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camouflage makeup improves quality of life in cancer patients with treatment-related skin changes.
Takako Wakeda, Tsuyoshi Okamura, Takuya Kawahara, Yuji Heike

Tumori· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Energy: A New Hypothesis in Decoding Cancer Evolution.
Hassan Akbari, Farzad Taghizadeh-Hesary, Yuji Heike, Moslem Bahadori

Arch Iran Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between consuming bivalves, and acute gastroenteritis and norovirus in Tokyo, Japan.
Daiki Kobayashi, Mayuko Saito, Yuji Heike, Kyoko Yokota, Hiroko Arioka

J Med Virol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome.
Yasunori Ueda, Michinori Ogura, Shigesaburo Miyakoshi, Takahiro Suzuki, Yuji Heike

Cancer Sci· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy.
Hirokazu Shoji, Kohei Tada, Shigehisa Kitano, Takashi Nishimura, Yasuhiro Shimada, Yuji Heike

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia.
Yukio Kobayashi, Toru Sakura, Shuichi Miyawaki, Kazuyuki Toga, Shinji Sogo, Yuji Heike

Cancer Immunol Immunother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of nivolumab-related pneumonitis.
Kohei Tada, Yasuyuki Kurihara, Tomohiro Myojo, Fumitsugu Kojima, Yuya Ishikawa, Yuji Heike

Immunotherapy· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CTIA-4 blockade therapy; biology and clinical activity].
Kohei Tada, Yuji Heike

Nihon Rinsho· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy.
Kohei Tada, Akiko Miyagi Maeshima, Nobuyoshi Hiraoka, Nobuhiko Yamauchi, Dai Maruyama, Yuji Heike

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Relationship between Wilms' Tumor Gene (WT1) Expression in Peripheral Blood of Acute Leukemia Patients and Serum IL-12 and C3 Levels.
Omran Rezai, Ali Khodadadi, Yuji Heike, Ali Mostafai, Nader Dashti Gerdabi

Asian Pac J Cancer Prev· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients.
Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, Takashi Nishimura, Yasuhiro Shimada, Yuji Heike

Cancer Immunol Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
Satoru Iwasa, Yasuhide Yamada, Yuji Heike, Hirokazu Shoji, Yoshitaka Honma

Cancer Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumor gene (WT1) expression correlates with vascular epithelial growth factor (VEGF) in newly acute leukemia patients undergoing chemotherapy.
Sara Iranparast, Mohammad-Ali Assarehzadegan, Yuji Heike, Mehran Hossienzadeh, Ali Khodadadi

Asian Pac J Cancer Prev· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients.
Nobuhiro Hiramoto, Saiko Kurosawa, Kinuko Tajima, Keiji Okinaka, Kohei Tada, Yuji Heike

Eur J Haematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases.
Shigeo Fuji, Niina Ueno, Nobuhiro Hiramoto, Yoshitaka Asakura, Kimikazu Yakushijin, Yuji Heike

Int J Hematol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.
Satoshi Yamasaki, Akiko Miyagi-Maeshima, Yasuo Kakugawa, Yoshihiro Matsuno, Fusako Ohara-Waki, Yuji Heike

Int J Hematol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation.
Wataru Munakata, Junko Nomoto, Noriko Takahashi, Hirokazu Taniguchi, Akiko Miyagi Maeshima, Yuji Heike

Am J Surg Pathol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis